Patient Augmented Reality and Vibratory Array Otorhinolaryngology Procedures
Launched by UNIVERSITY OF VIRGINIA · Jan 17, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how using vibration and augmented reality (AR) can help reduce anxiety and pain for patients undergoing certain procedures for throat-related issues, such as vocal fold polyps or vocal cord paralysis. In-office procedures are a safe and cost-effective way to treat these conditions, but some patients may struggle with discomfort or anxiety during the treatment. The trial will compare how patients feel during these procedures with and without the use of vibration and AR, looking at both their personal reports of pain and anxiety, as well as physiological signs of stress, like heart rate changes.
To participate in this study, patients should be between the ages of 65 and 74 and must be scheduled for an office-based throat procedure at the study site. There are no specific exclusions, so if you meet the age requirement and are having a procedure done, you could be eligible. Participants can expect to share their experiences through surveys and have their physiological responses monitored during the procedure, helping researchers understand how these new techniques might improve comfort and tolerance during treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing office-based laryngology procedure performed at home institution.
- Exclusion Criteria:
- • None
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Patients applied
Trial Officials
James J Daniero, MD
Principal Investigator
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported